Halozyme Therapeutics, Inc. (HALO)
63.08
-1.41
(-2.19%)
USD |
NASDAQ |
Apr 06, 16:00
63.05
-0.03
(-0.05%)
After-Hours: 07:26
Halozyme Therapeutics Profit Margin (Quarterly) : -31.34% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Skye Bioscience, Inc. | -- |
| Johnson & Johnson | 20.83% |
| Eli Lilly & Co. | 34.40% |
| Stryker Corp. | 11.84% |
| Glaukos Corp. | -93.39% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 91.50% |
| Return on Assets | 13.96% |
| Return on Invested Capital | 15.89% |
| Gross Profit Margin (Quarterly) | 77.39% |
| Operating Margin (Quarterly) | 56.31% |
| Return on Net Operating Assets | 20.55% |